what backs digital currency, Related searches

Bank of Communications International: For the first time, it covers the "buy" rating and target price of HK$ 5.86 given by the rich industrial trust. The Bank of Communications International published a report that the rich industrial trust has multiple investment advantages and stock price drivers, including stable profit prospects, low valuation, further interest rate cuts and potential inclusion in Shanghai-Shenzhen-Hong Kong Stock Connect, which are all beneficial to the valuation of REITs. For the first time, the bank covers the purchase of wealth and gives a "buy" rating with a target price of HK$ 5.86. Bank of Communications International believes that the rental income prospect of Zhifu Industrial Trust can remain basically stable. At the same time, the current share price corresponds to a dividend of 9.4% in 2025, and the gap between the dividend yield and the yield of 10-year US bonds is about 1.1 standard deviation lower than the long-term level. It is considered that the current valuation is still far below its long-term average level, and has reflected most of the worries of the retail market in Hong Kong. The report continued that although high interest rates will still have a negative impact on this year's earnings, it is expected that the dividend per unit of Zhifu will resume growth from next year under the condition of continuous interest rate reduction. It is expected that the dividend per unit will decrease by 10%, increase by 3.8% and increase by 4.1% from 2024 to 2026 to 36.34, 37.71 and 39.26 Hong Kong cents respectively.Li Qiang signed the the State Council Order to promulgate the Decision of the State Council on Amending and Abolishing Some Administrative Regulations, and the State Council Prime Minister Li Qiang recently signed the the State Council Order to promulgate the Decision of the State Council on Amending and Abolishing Some Administrative Regulations, which will take effect on January 20, 2025. In order to fully implement the spirit of the 20th National Congress of the Communist Party of China and the Second and Third Plenary Sessions of the 20th Central Committee, implement the spirit of institutional reform of the Party and the state, promote strict and standardized fair and civilized law enforcement, optimize the business environment ruled by law, and ensure a high level of opening to the outside world, the State Council cleaned up the administrative regulations involved, and decided to amend some provisions of 21 administrative regulations and abolish 4 administrative regulations. (Xinhua News Agency)Yiling Pharmaceutical Co., Ltd.: The application for clinical trial of Lianhua Yuping Granule was approved, and Yiling Pharmaceutical announced that Beijing Yiling, a wholly-owned subsidiary, received the Notice of Approval for Clinical Trial of Drugs approved and issued by National Medical Products Administration on December 12, 2024, and agreed to carry out clinical trial of Lianhua Yuping Granule for qi deficiency syndrome of common cold.

Alipay launched the commercial insurance code, and the first batch has been connected to Taikang and Zhongan medical insurance. On December 13th, Alipay launched the commercial insurance code. This means that after the patient has paid the medical insurance for hospitalization, if it needs to be supplemented, he can directly use the business insurance code to apply for prepayment of hospitalization expenses, and then initiate reimbursement claims to the insurance company. At present, users can open this service by searching for "business insurance code" on Alipay, and can apply for medical treatment quota according to the prompts. The first phase of the commercial insurance code has covered the mainstream millions of medical insurance under Taikang Online and Zhongan Online, and will cover more insurance institutions and insurance types in the future.Spot gold fell below $2,680 per ounce, down 1.38% in the day. COMEX gold futures fell 2.00% in the day and are now reported at $2701.50 per ounce.Yili shares: invested 130 million yuan to set up Anhui Jianwei Seed Fund. Yili shares announced that the company's wholly-owned limited partnerships, Jianwei Capital, Jianwei Seed Fund, Jianwei Parent Fund and Anhui Seed Fund jointly invested to set up Anhui Jianwei Seed Fund, with a total subscribed capital of 200 million yuan, and the company's wholly-owned limited partnerships contributed a total of 130 million yuan. The partnership term of the partnership enterprise is 12 years, and the fund can be extended twice for 1 year at the expiration of the term. The investment direction is mainly for the top ten emerging industries in Anhui Province, the future industries in the layout of new industries in various cities in the province and other key industries developed by the municipal government, focusing on small and medium-sized scientific and technological innovative enterprises with certain scientific and technological content and relatively new business models.

Market news: Israel said that the IDF will stay on the Syrian side of Mount Hermon for several months.US government audit: The FAA must take "urgent action" to modernize the air traffic control system after the shutdown in 2023.Borui Medicine: Carboprost injection is planned to win the bid for the national centralized drug procurement. Borui Medicine announced that in the tenth batch of national centralized drug procurement in which Borui Pharmaceutical, a wholly-owned subsidiary, participated, carboprost tromethamine injection is planned to win the bid. This product is mainly used for 13-20 weeks pregnant abortion and postpartum hemorrhage. The specification is 1 ml: 250μ g, and the proposed bid price is 16.96 yuan/piece. In the first year, the agreed purchase base is 220,400 pieces, which are mainly supplied to Henan, Hubei, Guangxi, Shaanxi, Gansu, Ningxia and other provinces. If the contract is finally selected and signed, it will help the product to quickly open the domestic market and enhance the market share and brand influence of the company. The product obtained the drug registration certificate in March 2024, and has not yet generated sales revenue.